September 25, 2023
The University of Cincinnati's Rhonna Shatz, DO, spoke with Healio about cognitive function during cancer survivorship.
March 24, 2022
The University of Cincinnati is enrolling patients for a new clinical trial testing a two-pronged immunotherapy approach to treat glioblastomas, deadly brain tumors.
March 29, 2022
CureToday highlighted the University of Cincinnati's new glioblastoma immunotherapy trial in a recent article.
September 23, 2022
The University of Cincinnati's Pankaj Desai, PhD, has received a $1.19 million grant from the National Institutes of Health/National Institute of Neurological Disorders and Stroke to continue research into the use of a drug called letrozole to treat glioblastomas, the most deadly form of brain tumors.
October 14, 2022
The University of Cincinnati's Soma Sengupta, MD, PhD, joined the Five to Thrive Live podcast to discuss "Humanizing Brain Tumors."
April 1, 2024
The University of Cincinnati's Brandon Foreman joined the iHeart Cinci Podcast to discuss traumatic brain injuries, including signs to look for and how to discuss the topic with your doctor.
November 17, 2022
The Cincinnati Enquirer featured the story of Dr. Alan Jobe, a Cincinnati Children's researcher who has beaten the odds of a glioblastoma diagnosis with the help of his team of University of Cincinnati physicians.
May 6, 2022
The University of Cincinnati's Soma Sengupta, MD, PhD, was featured in a VJOncology video discussing a recent Phase III glioma trial.
April 23, 2024
Local 12 spoke with patient Shane Shapiro and the University of Cincinnati's Laura Ngwenya about the importance of wearing a helmet following Shapiro's traumatic brain injury and recovery.
June 5, 2023
University of Cincinnati researchers have enrolled the first four patients in a first-of-its-kind trial that will test a treatment for abnormal brain activity sometimes referred to as a “brain tsunami.”